Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

414

Participants

Timeline

Start Date

May 29, 2012

Primary Completion Date

July 24, 2017

Study Completion Date

July 24, 2017

Conditions
Multiple SclerosisRRMS
Interventions
OTHER

Observational

Observational

Trial Locations (28)

189

Novartis Investigative Site, Roma

1081

Novartis Investigative Site, Amsterdam

2050

Novartis Investigative Site, Camperdown

3065

Novartis Investigative Site, Parkville

8036

Novartis Investigative Site, Barcelona

8091

Novartis Investigative Site, Zurich

10117

Novartis Investigative Site, Berlin

16132

Novartis Investigative Site, Genova

20132

Novartis Investigative Site, Milan

21287

Novartis Investigative Site, Baltimore

25018

Novartis Investigative Site, Montichiari

28040

Novartis Investigative Site, Madrid

35128

Novartis Investigative Site, Padua

39120

Novartis Investigative Site, Magdeburg

46026

Novartis Investigative Site, Valencia

52242

Novartis Investigative Site, Iowa City

70124

Novartis Investigative Site, Bari

94143-0359

Novartis Investigative Site, San Francisco

90509-2004

Novartis Investigative Site, Torrance

19104-4283

Novartis Investigative Site, Philadelphia

T2N 4Z1

Novartis Investigative Site, Calgary

J4V 2J2

Novartis Investigative Site, Greenfield Park

128 08

Novartis Investigative Site, Prague

DK-2100

Novartis Investigative Site, Copenhagen

09126

Novartis Investigative Site, Cagliari

90-153

Novartis Investigative Site, Lodz

08035

Novartis Investigative Site, Barcelona

EC1V 2PD

Novartis Investigative Site, London

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY